No definition available.
Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
C3_NONHODGKIN_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5397 |
4. Check minimum number of eventsNone |
5397 |
5. Include endpointsNone |
5397 |
6. Filter based on genotype QC (FinnGen only) |
5397 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5397 | 2358 | 3039 |
| Unadjusted period prevalence (%) | 1.11 | 0.80 | 1.34 |
| Median age at first event (years) | 65.57 | 64.38 | 66.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1247
- Matched controls
- 12471
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L03AA13
ATC
pegfilgrastim; parenteral
+∞
323.3
296
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
307
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4063.7
323.0
320
*
JN4BD
NOMESCO Finland
Extensive body CT
25.9
323.0
472
286
L03AA02
ATC
filgrastim; parenteral
673.3
323.0
345
7
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
323.0
345
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
289.7
323.0
802
77
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
323.0
382
*
XW000
NOMESCO Finland
Bone marrow biopsy
37.0
311.0
405
160
A03FA01
ATC
metoclopramide; systemic, rectal
14.3
283.6
540
632
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
761.1
258.4
246
*
WW500
NOMESCO Finland
Blood transfusion
35.0
239.7
315
119
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
231.6
215
*
H02AB02
ATC
dexamethasone; systemic
76.7
224.2
252
41
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2302.9
219.3
206
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
813.6
214.4
205
*
A04AA02
ATC
granisetron; systemic, transdermal
1096.3
196.4
187
*
M04AA01
ATC
allopurinol; systemic
7.4
194.4
578
1310
A04AA01
ATC
ondansetron; systemic, rectal
41.0
192.6
243
73
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
15.0
187.4
332
295
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
98.3
155.8
170
20
D70.82
ICD-10 Finland
Drug-induced neutropenia
161.8
150.1
156
11
Z51.5
ICD-10 Finland
Palliative care
19.6
144.7
226
139
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
142.5
134
*
JN4AD
NOMESCO Finland
Body CT examination
17.6
138.8
226
155
PJA10
NOMESCO Finland
Exploration of lymph nodes
146.6
136.4
143
11
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
133.8
126
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
29.6
132.6
181
71
WF049
NOMESCO Finland
Radiotherapy of metastasis
1361.5
128.5
123
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
128.4
121
*
ZX120
NOMESCO Finland
Intravenous
8.8
127.5
299
432
1XC02
NOMESCO Finland
NA
115.3
124.8
134
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.3
124.7
384
822
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
176.4
122.8
127
8
C61
ICD-10 Finland
Malignant neoplasm of prostate
1239.7
117.7
113
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
605.9
113.8
111
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
593.9
111.7
109
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
109.0
103
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
109.0
103
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
106.8
101
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
106.8
101
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
29.4
105.6
144
55
WW300
NOMESCO Finland
Transfer of autologic stem cells
1096.2
104.8
101
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
132.5
102.8
109
9
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
100.4
95
*
N02AA05
ATC
oxycodone; systemic
5.3
99.3
355
878
H02AB06
ATC
prednisolone; systemic
3.5
97.0
786
4044
L01AA02
ATC
chlorambucil; oral
+∞
93.9
89
*
R50.9
ICD-10 Finland
Fever, unspecified
5.0
92.9
348
898
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
89.7
85
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
85.4
81
*
JN6AD
NOMESCO Finland
CT of torso and neck
94.6
80.1
88
10
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
213.4
78.2
80
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
170.7
77.0
80
5
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
75.8
72
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
74.7
71
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
73.7
70
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
50.5
70.6
85
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.4
70.3
178
274
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.0
68.7
125
106
ZX112
NOMESCO Finland
Subcutaneous
33.3
68.5
90
29
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.0
67.9
204
395
WF002
NOMESCO Finland
Radical radiotherapy
107.4
65.6
71
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
65.0
401
1544
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
92.6
63.6
70
8
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
171.2
62.6
65
*
130
Kela drug reimbursment
Malignant tumour
+∞
60.9
58
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
322.9
60.9
61
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.1
60.8
133
161
116
Kela drug reimbursment
Prostate cancer
+∞
59.9
57
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
59.9
57
*
H02AB07
ATC
prednisone; oral
3.7
59.7
310
1033
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.3
59.4
103
78
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
605.5
59.2
58
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
58.8
56
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
56.6
255
749
J05AB11
ATC
valaciclovir; oral
4.2
55.9
235
647
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.6
53
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
288.5
54.6
55
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
71.1
53.6
61
9
WW409
NOMESCO Finland
Other aferesis
539.8
52.9
52
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
528.9
51.8
51
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
51.4
49
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
50.3
48
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
49.3
47
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
48.7
138
244
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
42.0
48.3
60
15
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
48.2
46
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
48.2
46
*
J01MA12
ATC
levofloxacin; systemic
3.0
48.1
344
1420
WZC30
NOMESCO Finland
Teaching
4.2
46.7
195
528
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
22.8
46.2
67
31
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
166.2
46.1
48
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
46.1
44
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
45.3
621
3675
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
31.4
45.3
60
20
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
45.1
43
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
233.1
44.2
45
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
44.0
42
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
44.0
42
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.9
42.9
111
173
WW402
NOMESCO Finland
Leucoferesis
+∞
41.9
40
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.8
41.4
124
234
TGC00
NOMESCO Finland
Bronchial lavation
8.2
41.3
95
124
B72
ICPC
Hodgkin Lymphoma
+∞
40.8
39
*
A02BC02
ATC
pantoprazole; systemic
2.3
40.7
819
5704
D70.89
ICD-10 Finland
Neutropenic splenomegaly
23.8
40.0
57
25
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
39.8
38
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
399.4
39.3
39
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
38.7
37
*
390
Kela drug reimbursment
Ibrutinib
+∞
38.7
37
*
L02AE02
ATC
leuprorelin; implant, parenteral
137.6
37.9
40
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
37.7
36
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
37.7
36
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.7
37.7
78
85
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.2
37.6
86
111
JN4CD
NOMESCO Finland
Very extensive body CT
10.2
37.1
75
78
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
37.1
222
796
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
36.6
35
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
36.6
35
*
ZX108
NOMESCO Finland
Inhalation
26.8
35.6
49
19
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
34.5
33
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
34.5
33
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
33.5
291
1310
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
33.5
32
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.0
32.7
94
168
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
32.4
31
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
32.4
31
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
32.4
31
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.2
30.7
122
311
212
Kela drug reimbursment
Gout
6.0
30.5
87
154
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
30.3
29
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
30.0
153
484
ZX070
NOMESCO Finland
Intensity modified radiotherapy
309.5
29.9
30
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
109.4
29.8
32
*
B01AB10
ATC
tinzaparin; parenteral
4.8
29.5
102
226
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
29.3
28
*
1512
Kela drug reimbursment
Ibrutinib
+∞
29.3
28
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
28.7
175
627
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
28.2
27
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
28.2
27
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
28.2
27
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
28.2
107
261
D69.5
ICD-10 Finland
Secondary thrombocytopenia
65.6
28.0
32
5
A79
ICPC
Malignancy NOS
148.3
27.7
29
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
27.2
26
*
1AA09
NOMESCO Finland
NA
+∞
27.2
26
*
L02BB03
ATC
bicalutamide; oral
+∞
27.2
26
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
27.2
26
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
27.2
26
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.2
27.0
106
267
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.8
27.0
69
106
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
26.9
449
2708
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
98.9
26.7
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
26.7
303
1547
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
26.1
25
*
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
26.1
25
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
74.3
25.9
29
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
25.8
149
513
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
25.7
282
1410
ZXE00
NOMESCO Finland
One hour or less
2.0
25.5
474
2966
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
25.1
24
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
132.6
24.7
26
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
24.0
23
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
24.0
23
*
TAB00
NOMESCO Finland
Lumbar puncture
5.2
23.9
76
154
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
27.3
23.6
32
12
A07AA02
ATC
nystatin; oral
3.5
23.5
114
345
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.5
23.2
55
76
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
55.1
23.1
27
5
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
23.0
22
*
J05AB01
ATC
aciclovir; systemic
2.3
22.8
251
1250
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
85.0
22.7
25
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
234.0
22.7
23
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
234.0
22.7
23
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
122.2
22.6
24
*
WW200
NOMESCO Finland
Immunization
6.7
22.6
58
90
B01AB05
ATC
enoxaparin; parenteral
2.0
22.3
362
2127
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
22.2
164
662
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
21.9
21
*
A04AD12
ATC
aprepitant; systemic
+∞
21.9
21
*
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
21.9
21
*
J01MA14
ATC
moxifloxacin; systemic
2.9
21.6
142
534
EMA10
NOMESCO Finland
Biopsy of tonsil
61.1
20.9
24
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
20.9
20
*
L01EL01
ATC
ibrutinib; oral
+∞
20.9
20
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
20.9
20
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
20.7
117
397
Z2446
NOMESCO Finland
Social worker
3.5
20.0
96
288
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
19.8
19
*
L01CB01
ATC
etoposide; systemic
+∞
19.8
19
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
19.8
19
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
19.8
19
*
C84.1
ICD-10 Finland
Sézary disease
+∞
19.8
19
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
19.8
19
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
19.0
79
210
HA1AA
NOMESCO Finland
X-ray mammography
6.9
18.9
47
70
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
18.8
18
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
18.8
18
*
L01BB05
ATC
fludarabine; systemic
+∞
18.8
18
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
18.8
18
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.8
18
*
115
Kela drug reimbursment
Breast cancer
+∞
18.8
18
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
18.8
18
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
18.8
18
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.4
18.8
41
50
C90.0
ICD-10 Finland
Multiple myeloma
192.7
18.6
19
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.5
18.6
67
156
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
44.7
18.3
22
5
127
Kela drug reimbursment
Transplant complication
9.5
18.2
37
40
L26
ICD-10 Finland
Exfoliative dermatitis
27.1
17.8
24
9
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
17.7
17
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
17.7
17
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
17.7
17
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
17.7
17
*
Y77
ICPC
Malignant neoplasm prostate
96.4
17.6
19
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
182.4
17.6
18
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.3
17.3
53
104
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
17.2
68
173
E83.50
ICD-10 Finland
Hypercalcemia
10.6
17.2
33
32
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
26.0
16.9
23
9
D07AB08
ATC
desonide; topical
2.5
16.7
142
617
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.7
16
*
L01BC06
ATC
capecitabine; oral
+∞
16.7
16
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
16.7
16
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
16.7
16
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
16.7
16
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
16.7
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.7
16
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.2
16.3
36
45
N02AX02
ATC
tramadol; systemic, rectal
1.7
16.1
494
3499
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
16.0
68
185
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
21.3
16.0
23
11
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
15.9
207
1097
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
60.8
15.8
18
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.7
15
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
15.7
15
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
15.7
15
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
15.7
15
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
15.7
15
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
15.7
15
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.5
348
2239
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.0
15.5
29
27
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
38.6
15.4
19
5
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
15.2
64
173
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
15.0
425
2929
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
14.9
500
3604
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
14.9
401
2720
J02AC03
ATC
voriconazole; systemic
57.4
14.8
17
*
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
25.4
14.7
20
8
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
14.6
14
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
14.6
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
14.6
14
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
14.6
14
*
Z2221
NOMESCO Finland
Medical doctor
1.8
14.5
302
1891
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
14.4
271
1642
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
14.3
58
152
N05CF01
ATC
zopiclone; oral
1.7
14.2
417
2891
HAB40
NOMESCO Finland
Wedge excision of mammary gland
43.0
14.1
17
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
11.0
14.0
26
24
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
11.0
14.0
26
24
H02AB09
ATC
hydrocortisone; systemic
5.3
13.9
42
82
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
53.9
13.8
16
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
24.1
13.8
19
8
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
7.4
13.8
32
44
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.6
13.8
26
25
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.8
13.7
23
17
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.1
13.6
30
38
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
13.6
13
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
13.6
13
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
13.6
13
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
13.6
13
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
13.6
13
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
13.6
13
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
34.4
13.5
17
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
13.5
173
907
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
16.4
13.5
21
13
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
141.4
13.5
14
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
141.4
13.5
14
*
R4110
NOMESCO Finland
Physiotherapy
1.8
13.4
281
1758
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.1
13.4
32
46
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
13.4
133
623
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
40.5
13.2
16
*
A98
ICPC
Health maint/preventive medicine
0.6
13.1
778
9060
ZZR00
NOMESCO Finland
Flap of skin
10.2
13.0
25
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
12.9
98
399
Z3231
NOMESCO Finland
Registered nurse
1.7
12.9
306
1986
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
12.4
12.6
22
18
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
32.4
12.6
16
5
B02.9
ICD-10 Finland
Zoster without complication
2.7
12.5
86
332
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
12.5
12
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
12.5
12
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
12.5
12
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
12.5
12
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
12.5
12
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
12.5
12
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
12.5
12
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
12.5
12
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
12.5
12
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
12.5
12
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
20.3
12.5
18
9
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
131.2
12.5
13
*
1CX01
NOMESCO Finland
NA
131.2
12.5
13
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
131.2
12.5
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
131.2
12.5
13
*
N03AX16
ATC
pregabalin; oral
1.8
12.4
249
1534
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
12.4
66
217
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.8
12.3
34
60
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
37.9
12.2
15
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
37.9
12.2
15
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
12.2
83
318
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
12.0
349
2393
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
47.1
11.9
14
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
6.5
11.9
30
47
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
7.1
11.8
28
40
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
65.6
11.6
13
*
134
Kela drug reimbursment
General erythroderma
11.2
11.6
21
19
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
11.5
61
200
1XX25
NOMESCO Finland
NA
+∞
11.5
11
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
11.5
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
11.5
11
*
9670/3-C42.1
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of bone marrow
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.5
11
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.5
11.4
39
88
UJF32
NOMESCO Finland
Coloscopy
1.7
11.4
279
1818
A06AH03
ATC
naloxegol; oral
17.2
11.2
17
10
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.6
11.1
31
56
D05BB02
ATC
acitretin; oral
4.0
11.0
43
110
L57.0
ICD-10 Finland
Actinic keratosis
2.2
11.0
108
505
ZXD05
NOMESCO Finland
Urgent procedure
1.6
10.9
363
2565
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
10.9
51
153
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.2
10.8
28
46
R06AE07
ATC
cetirizine; oral
1.6
10.8
390
2811
ZXC50
NOMESCO Finland
Cryotherapy
4.2
10.7
39
94
ED1AA
NOMESCO Finland
Mandipular X-ray examination
13.0
10.7
18
14
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.6
10.6
30
55
TK800
NOMESCO Finland
Hemodialysis
3.8
10.5
43
115
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.7
10.4
29
52
WX110
NOMESCO Finland
Local anesthesy
1.5
10.4
629
5068
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
110.9
10.4
11
*
V03AF03
ATC
calcium folinate; systemic
110.9
10.4
11
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
110.9
10.4
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
110.9
10.4
11
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
110.9
10.4
11
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
10.4
10
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
10.4
10
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
10.4
10
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
3AA13
NOMESCO Finland
NA
+∞
10.4
10
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
10.4
10
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
10.4
10
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
10.4
10
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
10.4
10
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
10.4
10
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
32.8
10.3
13
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
10.3
54
176
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
10.3
59
204
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.8
10.2
42
113
JFB00
NOMESCO Finland
Partial resection of small intestine
4.9
10.2
32
66
A02BC01
ATC
omeprazole; systemic
1.6
10.2
338
2377
E0000UV
ATC
NA
1.5
10.2
391
2850
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
10.1
276
1847
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
14.7
10.0
16
11
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.6
10.0
28
51
L01AA01
ATC
cyclophosphamide; systemic
12.3
9.9
17
14
B74
ICPC
Malignant neoplasm blood other
26.2
9.8
13
5
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
26.2
9.8
13
5
J02AC01
ATC
fluconazole; systemic
1.6
9.7
305
2113
C03CA01
ATC
furosemide; systemic
1.5
9.7
485
3741
AAA10
NOMESCO Finland
Biopsy through craniotomy
55.4
9.7
11
*
A41.8
ICD-10 Finland
Other specified sepsis
3.9
9.6
38
100
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
10.1
9.5
18
18
JMA10
NOMESCO Finland
Transabdominal total splenectomy
15.2
9.5
15
10
A05AA02
ATC
ursodeoxycholic acid; oral
7.2
9.5
22
31
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
9.5
55
192
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
9.5
21
662
TQW80
NOMESCO Finland
Local dermatologic skincare
3.8
9.5
39
106
ZX131
NOMESCO Finland
Intrathecal
100.7
9.4
10
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
100.7
9.4
10
*
ZX196
NOMESCO Finland
NA
100.7
9.4
10
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
100.7
9.4
10
*
DAB10
NOMESCO Finland
Partial excision of auricle
100.7
9.4
10
*
L04AD01
ATC
ciclosporin; systemic
4.6
9.4
31
68
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.2
9.4
28
55
TPX15
NOMESCO Finland
Removal of vascular injection port
30.2
9.4
12
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
17.7
9.4
14
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
9.4
34
82
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
9.4
9
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
9.4
9
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
9.4
9
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
9.4
9
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
9.4
9
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.4
9
*
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
7.0
9.3
22
32
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
13.8
9.2
15
11
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.4
9.1
31
71
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
8.7
116
616
120
Kela drug reimbursment
Hypogammaglobulinaemia
50.3
8.7
10
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
50.3
8.7
10
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
8.3
8.6
18
22
6BA02
NOMESCO Finland
NA
16.4
8.6
13
8
WF099
NOMESCO Finland
Other radiotherapy
27.7
8.5
11
*
L41.8
ICD-10 Finland
Other parapsoriasis
27.7
8.5
11
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
27.7
8.5
11
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
27.7
8.5
11
*
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
27.7
8.5
11
*
4701
FHL
Neck lymph node removal
27.7
8.5
11
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.7
8.5
35
96
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.4
8.4
70
301
HAC20
NOMESCO Finland
Total mastectomy
90.6
8.4
9
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
90.6
8.4
9
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.1
8.4
25
50
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
8.3
8
*
3AX16
NOMESCO Finland
NA
+∞
8.3
8
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
8.3
8
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
8.3
8
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
8.3
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.3
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
8.3
8
*
B73
ICPC
Leukaemia
+∞
8.3
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.3
8
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
+∞
8.3
8
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
8.3
8
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
8.3
8
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
8.3
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.3
8
*
N02AA01
ATC
morphine; systemic, rectal
6.3
8.3
21
34
P20
ICPC
Memory disturbance
0.5
8.3
76
1389
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.8
8.3
26
55
J01DB01
ATC
cefalexin; oral
1.4
8.3
844
7390
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
8.2
77
352
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
8.2
63
261
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.0
8.2
31
79
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.7
8.1
22
39
ZQZ00
NOMESCO Finland
Treatment of several skin areas
33.6
8.1
10
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
9.0
8.0
16
18
EMB10
NOMESCO Finland
Tonsillectomy
3.6
8.0
34
96
L04AA06
ATC
mycophenolic acid; systemic
4.8
8.0
25
53
C10AA07
ATC
rosuvastatin; oral
0.6
7.9
130
2036
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
45.2
7.7
9
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
18.5
7.6
11
6
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
7.6
31
749
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
7.5
36
112
N06DX01
ATC
memantine; oral
0.4
7.5
37
830
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
80.5
7.4
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.5
7.4
8
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
80.5
7.4
8
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
80.5
7.4
8
*
S77
ICPC
Malignant neoplasm of skin
80.5
7.4
8
*
R4190
NOMESCO Finland
Nutritional therapy
4.1
7.4
27
67
GEA00
NOMESCO Finland
Mediastinoscopy
13.4
7.4
12
9
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.4
198
1314
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
7.3
7
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
L41.4
ICD-10 Finland
Large plaque parapsoriasis
+∞
7.3
7
*
3AF07
NOMESCO Finland
NA
+∞
7.3
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
7.3
7
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
7.3
7
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
9.4
7.3
14
15
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
7.2
50
196
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
30.2
7.2
9
*
L02AE03
ATC
goserelin; implant
30.2
7.2
9
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
20.1
7.1
10
5
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.9
7.1
27
70
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
12.1
7.1
12
10
WW200
SPAT
NA
0.3
7.1
20
560
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
10.1
7.0
13
13
L02BG04
ATC
letrozole; oral
10.1
7.0
13
13
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
10.1
7.0
13
13
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.0
7.0
26
66
Z51.88
ICD-10 Finland
Other specified medical care
3.7
7.0
28
76
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.9
6.9
18
31
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
11.0
6.8
12
11
A06AD11
ATC
lactulose; oral
1.6
6.8
209
1433
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
40.3
6.8
8
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
40.3
6.8
8
*
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
40.3
6.8
8
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.0
6.8
36
122
D07AA02
ATC
hydrocortisone; topical
1.7
6.7
130
784
C10AA01
ATC
simvastatin; oral
0.7
6.7
423
5171
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
7.2
6.7
15
21
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
22.6
6.7
9
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.5
6.6
16
25
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.6
6.6
21
46
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.5
6.6
47
190
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
8.7
6.6
13
15
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.3
6.5
31
97
A10BK03
ATC
empagliflozin; oral
0.3
6.5
12
414
D07AC01
ATC
betamethasone; topical
1.4
6.5
357
2756
RS221
NOMESCO Finland
NA
4.5
6.5
21
47
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
6.5
215
2925
N06DA02
ATC
donepezil; oral
0.4
6.5
30
691
JAH01
NOMESCO Finland
Laparoscopy
3.2
6.4
31
98
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
70.2
6.4
7
*
1XX32
NOMESCO Finland
NA
70.2
6.4
7
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
70.2
6.4
7
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
70.2
6.4
7
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
6.4
150
2185
G04BE03
ATC
sildenafil; oral
14.4
6.4
10
7
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
14.4
6.4
10
7
J94.8
ICD-10 Finland
Other specified pleural conditions
3.7
6.4
26
72
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.9
6.4
19
39
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.6
6.4
45
180
XQ848
NOMESCO Finland
Dermatological photography
3.5
6.3
27
78
N05AX08
ATC
risperidone; systemic
0.5
6.3
36
767
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.0
6.3
16
27
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
11.1
6.3
11
10
L04AA01
ATC
[U] ciclosporin; systemic
4.6
6.3
20
44
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.3
320
2431
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
6.3
235
3132
KAC10
NOMESCO Finland
Total nephrectomy with capsule
18.1
6.3
9
5
372
Kela drug reimbursment
Idelalisib
+∞
6.3
6
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
6.3
6
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
6.3
6
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
9670/3-C77.4
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
6.3
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
6.3
6
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
6.3
6
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
6.3
6
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
6.3
6
*
L01XX47
ATC
[U] idelalisib; oral
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
6.3
6
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
+∞
6.3
6
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
6.3
6
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
6.3
6
*
2AX05
NOMESCO Finland
NA
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
6.3
6
*
3AA02
NOMESCO Finland
NA
+∞
6.3
6
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
6.2
75
386
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
26.8
6.2
8
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
26.8
6.2
8
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
26.8
6.2
8
*
L03AB05
ATC
interferon alfa-2b; parenteral
26.8
6.2
8
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.1
6.2
22
54
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
6.2
31
101
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.9
6.1
35
122
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
12.6
6.1
10
8
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.4
6.1
27
81
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.4
6.1
20
46
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.0
138
876
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020630) Protein [Mass/volume] in Serum or Plasma
1182
3682
3.83
323.31
3.2
1.6
g/l
64.5
66.8
14.54
1126
3250
(40768804) Tissue Pathology biopsy report
2624
13151
2.94
322.61
2.6
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3370
19337
2.98
320.91
10.3
5.4
mmol/l
1.2
1.2
6.67
3241
17071
(40760892) CBC W Ordered Manual Differential panel - Blood
1954
8372
3.09
318.88
9.6
4.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
423
549
8.28
308.50
1.3
1.2
u/ml
294.7
285.3
0.18
261
335
(3011412) CD3 cells [#/volume] in Blood
829
234
41.68
307.65
2.8
1.9
e9/l
1.1
1.0
0.88
583
133
(3021879) Hepatitis B virus core Ab [Presence] in Serum
2158
2009
17.23
307.65
1.4
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3497
4247
21.55
307.65
8.1
2.7
u/l
267.1
239.6
6.39
3413
3916
(40765096) Chromosome analysis panel by Banding
383
56
73.54
307.65
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
446
536
8.98
307.65
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
629
817
8.58
307.65
2.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2570
11547
3.34
307.65
8.2
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
4090
18954
5.78
307.65
11.8
5.9
%
9.6
8.8
35.48
3995
17467
(3005719) IgG [Mass/volume] in Serum or Plasma
1719
2677
8.96
307.65
4.1
2.2
g/l
8.8
10.8
45.13
1650
2435
(3006245) CD3-CD19+ cells/100 cells in Blood
331
87
40.47
307.65
2.4
1.9
%
10.3
11.1
0.18
297
79
(21494815) CD4 cells/100 lymphocytes in Specimen
613
202
34.11
307.65
2.4
2.0
%
27.5
47.4
5.66
60
28
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
524
173
33.44
307.65
3.0
1.8
e6/l
570.2
439.7
2.83
440
148
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
641
854
8.38
307.65
2.4
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
542
523
11.41
307.65
4.9
2.8
%
1.7
1.3
1.30
450
389
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
920
54
205.18
307.65
1.4
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
905
2287
4.55
307.65
2.5
1.5
ug/l
10.9
9.2
0.10
658
1708
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
650
608
12.02
307.65
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
576
536
11.91
307.65
1.4
1.5
u/ml
117.3
122.5
0.15
156
108
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
686
175
44.76
307.65
2.3
1.9
%
15.0
15.5
0.13
307
79
(3017143) Hepatitis C virus Ab [Presence] in Serum
2354
3287
11.93
307.65
1.5
1.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
510
164
34.24
307.65
3.1
1.8
e9/l
0.2
0.2
0.02
441
146
(3019198) Lymphocytes [#/volume] in Blood
4257
20858
5.93
307.65
10.7
5.5
e9/l
1.9
1.8
0.44
3938
18105
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
257
66
40.84
307.65
3.3
1.4
u/l
46.6
39.5
0.11
242
59
(3026493) Urate [Moles/volume] in Serum or Plasma
3135
11775
4.97
307.65
5.9
2.5
umol/l
1309.3
5742.5
13.28
3032
9961
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
333
256
13.80
307.65
1.7
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
4033
19191
5.36
307.65
10.6
5.6
%
56.3
57.8
10.61
3936
17673
(3001604) Monocytes [#/volume] in Blood
4237
20293
6.06
307.65
10.5
5.4
e9/l
0.6
0.6
0.28
3877
17312
(3028026) IgM [Mass/volume] in Serum or Plasma
1237
2120
7.27
307.65
3.3
1.4
g/l
1.7
1.1
5.46
1168
1912
(3025159) Blasts/100 leukocytes in Blood
1110
3009
4.39
307.65
6.3
3.8
%
0.1
0.4
0.72
603
579
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
751
432
20.03
307.65
3.0
2.7
u/ml
13747.5
514.2
1.11
79
29
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
834
570
17.12
307.65
5.6
5.6
iu/ml
2075.2
776.9
0.35
132
82
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4141
20436
5.41
307.65
15.0
3.8
umol/l
10.7
12.1
10.04
4072
19065
(3027945) Reticulocytes/100 erythrocytes in Blood
1742
5036
4.63
307.65
4.0
2.1
%
1.8
1.8
0.72
1633
4371
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
521
589
9.68
307.65
2.5
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1447
3781
4.86
307.65
4.0
2.2
e9/l
70.3
68.6
0.93
1218
2888
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
382
167
24.54
307.65
1.7
1.4
mg/l
3.7
4.4
0.96
365
161
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
660
893
8.28
307.65
1.8
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
1069
542
24.35
307.65
1.7
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4282
21116
5.98
307.65
11.4
5.6
e9/l
0.2
0.2
21.63
3947
18291
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1932
6233
4.27
307.65
6.9
2.6
mmol/l
0.8
0.8
7.03
1862
5695
(3002030) Lymphocytes/100 leukocytes in Blood
4097
19382
5.62
307.65
11.5
5.7
%
27.4
27.2
0.35
3999
17749
(1175426) CD3 cells/100 lymphocytes in Blood
691
180
43.88
307.65
2.3
1.9
%
73.3
71.0
0.96
664
168
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
486
182
29.25
307.65
3.2
1.8
e6/l
445.8
734.9
4.97
183
78
(21494814) CD8 cells/100 lymphocytes in Specimen
363
89
43.66
307.65
2.2
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
539
828
7.12
307.65
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
1106
299
46.27
307.65
1.6
1.1
—
—
—
0
0
(4035726)
2039
1213
26.41
307.65
1.8
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2409
3677
11.03
307.65
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
4379
22437
6.05
307.65
24.7
6.3
e9/l
3.6
4.3
100.14
4094
19181
(3017181) Myelocytes/100 leukocytes in Blood
1423
3295
5.51
307.65
6.3
3.7
%
1.0
0.8
3.00
842
725
(42870588) Differential panel, method unspecified - Blood
3456
13781
5.19
307.65
10.4
5.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
4246
20426
6.06
307.65
10.6
5.4
e9/l
0.0
0.0
13.21
3886
17448
(3006504) Eosinophils/100 leukocytes in Blood
4078
18852
5.76
307.65
11.2
5.6
%
2.7
3.0
8.19
3985
17305
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
464
588
8.54
307.65
1.3
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
511
148
38.03
307.65
2.9
2.0
e9/l
0.2
0.1
0.83
504
142
(40768795) Lymph node Pathology biopsy report
1203
86
179.72
307.65
1.4
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
4047
18334
5.83
307.65
11.0
5.7
%
0.7
0.7
1.51
3952
16851
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
332
89
39.68
307.65
2.4
1.8
%
34.5
25.9
6.37
309
82
(3016228) CD19 cells/100 cells in Blood
368
94
41.94
307.65
2.2
2.0
%
5.4
7.4
1.15
363
89
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
333
73
48.55
307.65
2.2
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3645
17771
4.24
307.65
8.4
3.8
g/l
34.3
35.5
28.11
3515
16166
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1520
5425
3.51
307.65
7.3
5.5
mmol/l
1.0
1.0
0.38
1467
4961
(3021440) Promyelocytes/100 leukocytes in Blood
1279
3171
4.98
307.65
6.5
3.7
%
0.2
0.1
4.06
767
670
(3000060) B lymphocytes [#/volume] in Blood
234
53
46.11
307.65
2.3
1.9
e6/l
516.9
155.8
0.83
98
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
2548
4442
9.97
307.65
1.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1250
3031
5.07
307.65
6.0
3.6
%
0.7
0.5
1.31
574
530
(3004588) Protein electrophoresis panel - Serum or Plasma
1157
3190
4.34
307.65
2.6
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3677
21407
3.25
307.65
11.8
5.8
mmol/l
1.2
1.2
7.64
3095
17895
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
680
166
46.73
307.65
2.4
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2672
13296
3.00
307.65
7.1
2.1
mmol/l
2.4
2.4
0.34
2488
11003
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
449
141
34.64
307.65
3.8
2.3
%
34.3
41.0
2.22
183
54
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
170
29
60.49
305.37
1.7
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
232
122
19.83
298.30
4.5
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1773
7595
2.99
284.06
5.3
2.2
mmol/l
2.5
2.4
9.15
1700
6475
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3119
17901
2.76
283.86
6.9
3.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
446
676
7.10
283.29
1.9
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
2041
9459
2.86
282.22
17.7
4.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
2424
12302
2.76
280.87
8.2
3.3
ph
7.4
7.4
1.38
598
2181
(3032352) Blasts [#/volume] in Cerebral spinal fluid
146
18
83.34
275.63
1.8
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
316
326
10.23
275.21
2.6
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
329
360
9.67
274.36
2.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2340
11815
2.73
271.74
4.5
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
380
506
8.00
270.70
2.0
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4527
32095
3.55
270.06
19.4
5.4
u/l
82.6
76.3
16.36
4453
29595
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1663
7091
2.94
266.09
2.9
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
325
367
9.36
264.53
5.7
3.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
273
248
11.54
259.52
2.5
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
937
2867
3.74
259.13
2.3
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
186
81
23.75
258.59
4.0
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
622
1407
4.87
257.74
2.4
3.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
263
237
11.61
251.29
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
372
537
7.37
246.57
1.8
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3046
18073
2.57
246.28
18.0
8.7
e9/l
0.0
0.0
0.53
2609
14733
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
319
385
8.74
246.26
2.0
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
297
352
8.87
232.50
5.1
2.6
%
54.5
60.2
2.48
201
224
(3002256) Pathology report gross observation
957
3198
3.42
229.38
1.4
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
456
881
5.56
225.83
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
349
519
7.12
224.87
1.9
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
423
780
5.80
220.19
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
367
595
6.55
217.77
2.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1568
7109
2.70
216.63
2.4
1.3
g/l
2.0
2.6
17.41
1261
4017
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
273
322
8.88
214.38
1.3
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
119
23
52.88
208.39
1.5
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1824
9085
2.52
205.73
4.2
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
138
50
28.30
204.86
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1208
4934
2.87
202.64
2.5
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4327
31825
2.81
202.59
7.0
4.2
mm/h
16.1
12.4
33.05
4181
29153
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1207
4937
2.86
201.85
2.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
253
297
8.89
199.31
2.8
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
253
297
8.89
199.31
2.8
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
253
297
8.89
199.31
2.8
1.2
—
—
—
0
0
(44790047)
289
404
7.50
196.65
1.9
1.4
—
—
—
0
0
(44790049)
289
404
7.50
196.65
1.9
1.4
—
—
—
0
0
(44806118)
289
404
7.50
196.65
1.9
1.4
—
—
—
0
0
(44790048)
289
404
7.50
196.65
1.9
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
167
108
15.92
193.76
1.8
2.1
u/ml
4018.7
108569.9
0.64
22
16
(21494434) Karyotype in Bone marrow
257
322
8.33
192.03
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1884
9829
2.41
188.87
5.9
3.6
%
87.2
86.2
1.08
1846
9567
(3032080) INR in Blood by Coagulation assay
2868
18069
2.25
181.77
10.1
10.6
inr
1.2
1.3
11.19
792
4975
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
151
92
16.86
180.58
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
593
1693
3.81
178.45
2.6
1.8
ug/l
2.3
1.7
0.48
549
1457
(3042936) Bacteria identified in Isolate by Culture
1283
5790
2.60
174.02
2.1
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
157
112
14.41
172.63
3.4
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
155
113
14.09
168.33
3.4
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
155
113
14.09
168.33
3.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
378
816
4.91
163.98
2.2
1.8
u/ml
166.3
101.5
0.49
300
656
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
518
1438
3.88
161.81
3.1
1.5
mg/l
37.4
39.3
0.13
426
1145
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
170
156
11.22
160.06
3.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
170
156
11.22
160.06
3.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
170
156
11.22
160.06
3.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
170
156
11.22
160.06
3.3
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
528
1504
3.78
158.84
3.0
1.5
g/l
1.4
0.5
5.70
469
1262
(3034860) Kappa light chains.free [Mass/volume] in Serum
514
1440
3.84
158.37
3.1
1.5
mg/l
59.0
48.6
1.28
426
1153
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
589
1809
3.53
158.27
2.9
1.4
g/l
7.2
7.5
1.77
455
1311
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
588
1808
3.53
157.70
2.9
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
587
1803
3.53
157.69
2.9
1.4
g/l
3.7
3.9
0.46
447
1259
(3037692) Legionella sp identified in Specimen by Organism specific culture
156
129
12.42
157.10
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1003
4205
2.70
156.31
5.2
2.2
umol/l
7.8
8.1
0.16
910
3607
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
114
53
21.95
154.04
2.5
1.0
u/ml
24.1
16.0
1.35
108
45
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
497
1394
3.83
152.73
3.2
1.5
ratio
7.7
2.3
0.79
35
127
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
403
983
4.35
149.91
3.3
2.4
g/l
3.7
3.5
0.88
389
929
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
625
2068
3.29
148.85
2.0
1.6
g/l
1.6
1.5
0.84
512
1760
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
180
199
9.32
148.30
1.3
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1367
6775
2.36
148.22
3.2
1.9
s
29.4
30.0
3.04
1332
6562
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
551
1692
3.51
147.75
3.0
1.4
g/l
3.3
3.0
4.99
451
1286
(3013826) Glucose [Moles/volume] in Serum or Plasma
3541
25494
2.13
145.28
7.5
4.5
mmol/l
6.7
6.9
8.07
3434
23764
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
541
1678
3.47
142.68
2.8
1.4
g/l
9.5
10.3
2.81
487
1382
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
471
1333
3.78
142.62
2.9
1.4
g/l
0.1
0.0
0.64
448
1200
(3042631) Mycobacterium sp identified in Specimen
289
559
5.41
141.99
2.1
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
279
524
5.56
141.58
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
98
42
23.75
136.69
1.6
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
427
1176
3.86
134.29
1.7
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
233
390
6.20
133.31
1.3
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
317
702
4.74
132.97
6.0
3.5
%
56.0
58.7
2.59
317
702
(3013727) Leukocytes other/100 leukocytes in Blood
124
93
13.62
132.36
4.2
3.0
%
48.4
60.8
4.80
124
88
(3002582) Erythrocytes [#/volume] in Urine
2089
12733
2.05
131.23
3.9
3.1
e6/l
33.4
83.7
4.00
1673
9701
(40760888) Immunoglobulin light chains.free panel - Serum
398
1061
3.97
131.01
3.1
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
130
6
221.95
126.35
1.1
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
425
1216
3.71
126.30
3.0
1.5
g/l
0.0
0.0
0.00
407
1105
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
427
1241
3.65
123.92
3.0
1.5
g/l
0.0
0.0
0.50
407
1110
(3003694) ABO and Rh group [Type] in Blood
1715
9909
2.07
123.08
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
163
205
8.17
121.11
2.2
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
176
243
7.45
120.71
2.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1931
11722
2.01
120.22
3.8
3.0
e6/l
0.4
0.5
0.25
1514
8759
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
195
303
6.64
119.95
2.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
162
206
8.08
119.26
2.2
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
455
1416
3.42
118.75
2.9
1.4
g/l
36.5
37.6
3.16
420
1176
(3018095) Leukocytes [#/volume] in Urine
2288
14852
1.94
116.10
4.6
3.5
e6/l
145.5
105.3
0.53
1748
10473
(3008536) Aspergillus sp Ab [Presence] in Serum
96
57
17.13
116.08
2.9
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1860
11263
1.99
115.64
3.7
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
144
165
8.94
115.31
1.9
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
143
165
8.88
113.88
1.9
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
243
514
4.90
107.50
6.2
6.4
mg/l
11.4
12.1
1.46
225
461
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
249
542
4.77
106.43
1.1
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3613
27773
1.91
103.82
5.5
4.4
e6/l
940.4
2188.4
0.95
70
420
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
720
3151
2.48
99.54
2.2
2.1
g/l
0.2
0.2
3.27
667
2848
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
265
646
4.26
98.11
1.3
1.2
miu/ml
120.5
205.1
2.24
47
253
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
373
1153
3.40
98.00
1.7
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1101
5803
2.13
97.72
2.5
2.7
%
23.4
22.6
0.83
983
4833
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
125
148
8.62
97.50
1.3
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
1414
8176
1.99
97.30
3.2
2.6
mosm/kgh2o
537.7
552.4
1.89
1258
6829
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
72
35
20.84
95.29
1.5
2.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1494
8897
1.94
93.75
3.0
2.5
e6/l
4.3
4.7
0.90
1341
7687
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1140
6218
2.06
91.68
2.4
2.6
g/l
2.2
2.3
10.30
1072
5691
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
334
1010
3.46
90.73
1.8
1.2
mg/l
685.6
531.6
2.62
323
943
(3000991) Gas panel - Venous blood
754
3518
2.33
89.76
8.3
8.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
339
1048
3.38
88.92
1.9
1.9
mg/l
11.6
11.5
0.06
317
960
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
304
877
3.61
88.73
1.9
1.3
e6/l
41.6
26.4
0.34
255
676
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
596
2521
2.53
88.08
1.8
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
68
35
19.66
87.77
1.2
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
303
879
3.59
87.68
1.9
1.4
e6/l
7233.1
1088.5
0.44
259
717
(3022948) Iron [Moles/volume] in Serum or Plasma
1201
6773
1.99
87.49
2.5
2.6
umol/l
12.8
12.9
0.09
1130
6192
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
734
3445
2.31
85.96
9.4
3.1
mmol/l
1.2
1.2
1.21
711
2912
(3028433) Virus identified in Specimen by Culture
107
124
8.78
84.87
1.4
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
184
378
5.00
84.14
3.4
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
395
1383
3.00
84.00
3.4
3.2
u/ml
0.4
0.3
0.35
241
798
(3000494) Fungus identified in Specimen by Culture
925
4829
2.10
82.86
1.8
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
449
1701
2.79
82.58
1.4
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
789
3878
2.21
82.44
8.1
7.0
mmol/l
10.3
10.9
1.58
768
3661
(3044290) Cell count panel - Cerebral spinal fluid
275
782
3.65
81.94
1.9
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
207
481
4.44
81.45
1.6
1.5
g/l
31.1
28.6
2.00
196
421
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1148
6604
1.94
77.80
3.5
2.8
e6/l
2.2
2.4
0.17
651
3584
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
68
48
14.33
74.98
1.8
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1686
11042
1.77
74.73
2.2
2.3
mg/l
3.4
3.0
7.14
1473
9326
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
435
1709
2.68
74.35
1.8
1.8
u/l
42.5
38.3
3.26
390
1454
(3002032) Base excess in Venous blood by calculation
823
4269
2.09
74.34
5.2
3.6
mmol/l
1.9
1.9
0.04
677
3478
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2093
14585
1.71
74.13
3.6
3.1
ng/l
1825.9
1543.6
1.56
1888
12534
(3012544) pH of Venous blood
847
4451
2.07
73.85
5.2
3.7
ph
7.4
7.4
—
5
26
(40768806) Pleura Pathology biopsy report
161
331
4.98
73.54
1.6
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
135
239
5.77
72.77
1.6
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
819
4286
2.07
72.09
5.2
3.6
kpa
5.7
5.8
3.14
799
4146
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
281
882
3.31
71.74
1.8
1.2
mmol/l
3.7
3.9
2.37
266
821
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
156
319
5.01
71.70
1.3
1.3
u/l
341.2
304.7
0.30
143
302
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
309
1033
3.11
71.03
3.2
2.1
%
89.6
90.2
0.17
304
968
(3014576) Chloride [Moles/volume] in Serum or Plasma
958
5328
1.97
71.02
9.5
6.5
mmol/l
104.3
104.3
0.09
928
5195
(3026008) Bacteria identified in Urine by Culture
1871
12799
1.71
69.91
3.6
3.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1923
13344
1.69
67.55
3.0
2.3
u/l
55.0
59.6
1.49
1787
12163
(3001964) Herpes simplex virus Ag [Presence] in Specimen
89
110
8.21
67.02
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1836
12632
1.69
66.32
6.3
2.6
u/l
34.6
34.8
0.05
1751
11830
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
134
260
5.26
65.39
2.8
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
160
361
4.54
65.31
1.6
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
423
1745
2.55
65.25
1.5
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3589
29318
1.67
65.17
5.2
4.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
191
496
3.96
64.77
2.2
2.0
u/ml
641.4
312.9
0.26
167
449
(3014111) Lactate [Moles/volume] in Serum or Plasma
720
3747
2.06
63.81
7.3
6.6
mmol/l
1.5
1.4
1.54
698
3590
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1182
7255
1.81
63.70
3.3
2.6
e6/l
1.0
1.2
0.62
681
4207
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
804
4364
1.99
63.33
5.6
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
555
2621
2.25
63.07
2.1
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
172
425
4.15
62.42
1.2
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
663
3375
2.10
62.25
2.3
1.8
nmol/l
370.4
367.0
0.17
630
3024
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
51
30
17.15
61.76
5.6
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
75
84
9.04
61.06
1.7
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2248
16558
1.61
60.48
3.3
2.8
ug/l
374.0
137.4
25.15
2093
15072
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
304
1105
2.86
60.09
2.6
1.5
u/ml
76.7
28.8
2.46
293
1045
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
284
1003
2.93
59.16
5.1
3.1
mg/l
1.5
1.7
2.04
263
885
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1382
9033
1.71
59.12
2.1
1.7
mg/l
1.8
1.2
3.87
1129
6897
(3023199) Leukocytes [#/volume] in Pleural fluid
167
427
4.00
57.86
1.5
1.5
e6/l
2095.3
2672.2
0.39
119
313
(3009343) pH of Capillary blood
576
2882
2.12
56.32
4.7
3.6
ph
7.4
7.4
1.54
81
344
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
580
2922
2.10
55.67
4.7
3.6
kpa
5.0
5.2
2.92
556
2672
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
452
2072
2.29
54.90
6.3
4.0
mmol/l
24.5
24.2
1.12
420
1827
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
263
928
2.93
54.84
1.2
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
153
382
4.09
54.76
1.5
1.5
e6/l
47991.7
63162.1
0.21
88
222
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
116
232
5.09
54.71
1.3
1.3
u/l
29.2
11.0
1.75
107
205
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
557
2785
2.12
54.49
4.6
3.5
mmol/l
2.4
1.8
3.21
464
2021
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
72
89
8.19
54.21
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
408
1800
2.37
54.14
3.4
1.7
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
154
391
4.02
53.87
1.6
1.8
titre
3600.0
1670.0
—
5
16
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
70
85
8.33
53.47
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
134
309
4.42
53.23
1.4
1.4
mmol/l
6.2
6.7
1.06
127
278
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
151
383
4.03
52.90
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
140
336
4.25
52.81
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
66
77
8.67
52.05
1.3
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
36
14
25.88
51.68
1.9
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
152
401
3.87
50.42
1.8
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2287
17409
1.54
50.38
2.4
2.2
nmol/l
78.2
78.7
0.34
2111
15207
(3025468) Yersinia sp identified in Specimen by Organism specific culture
170
485
3.59
50.32
2.7
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
543
2777
2.06
49.83
3.1
3.0
e9/l
4.0
4.1
0.38
407
2009
(3019225) pH of Specimen
769
4430
1.86
49.76
7.2
3.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
169
484
3.57
49.73
2.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
169
487
3.55
49.27
2.7
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4680
42151
1.83
48.62
36.9
13.6
mg/l
24.0
24.3
0.27
4339
32994
(3025941) Bacteria identified in Stool by Culture
440
2095
2.20
48.58
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
244
884
2.84
48.44
2.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
169
494
3.50
48.21
2.7
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
818
4854
1.81
47.94
1.9
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
95
179
5.38
47.92
2.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
95
179
5.38
47.92
2.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
168
493
3.49
47.64
2.7
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
142
372
3.89
47.58
1.4
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
62
75
8.35
47.50
2.3
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
636
3494
1.93
47.50
2.5
2.2
u/l
35.3
51.7
0.62
547
2949
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1341
9125
1.62
47.39
4.2
4.0
ng/l
337.8
531.0
0.69
1149
7555
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
170
506
3.44
47.16
2.7
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
68
95
7.24
46.12
2.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
103
219
4.78
45.25
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
364
1661
2.28
44.49
2.4
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
248
948
2.69
44.43
3.5
2.3
%
224.1
189.3
5.99
237
900
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
109
251
4.41
43.40
2.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
107
246
4.42
42.70
2.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
423
2113
2.09
41.11
5.1
3.7
—
—
—
0
0
(3024471) HLA-A [Type]
66
103
6.47
40.42
1.0
1.0
—
—
—
0
0
(3036489) Thrombin time
309
1370
2.33
40.35
3.0
1.9
s
22.9
21.4
2.00
291
1201
(3045788) Cell count panel - Pleural fluid
122
325
3.82
39.95
1.5
1.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
28
11
25.58
39.91
2.4
5.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
810
5044
1.71
39.52
8.7
7.0
mmol/l
1.3
1.2
0.24
630
3882
(21494890) Protein electrophoresis panel - 24 hour Urine
141
418
3.44
39.39
1.9
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
139
410
3.45
39.13
1.5
1.4
g/l
6.0
6.8
1.28
98
286
(3024139) IgG subclass 3 [Mass/volume] in Serum
139
410
3.45
39.13
1.5
1.4
g/l
0.3
0.4
2.78
97
289
(3028192) IgG subclass 2 [Mass/volume] in Serum
139
410
3.45
39.13
1.5
1.4
g/l
2.3
2.9
3.10
99
287
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2279
17965
1.46
39.03
4.5
3.9
ng/l
39.0
74.9
1.90
1867
13144
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
180
625
2.94
38.62
1.1
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
181
632
2.93
38.45
1.5
1.6
g/l
0.6
0.8
1.61
130
478
(4062490)
138
410
3.43
38.42
1.5
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
809
5077
1.70
38.26
8.6
6.9
kpa
12.2
11.5
2.72
771
4810
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
809
5080
1.70
38.17
8.6
7.0
kpa
5.0
5.1
0.87
765
4829
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
95
218
4.42
38.03
2.7
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
95
221
4.36
37.37
1.2
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
70
127
5.57
36.83
1.7
1.4
%
64.3
64.2
0.01
59
103
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
276
1224
2.32
35.99
1.6
1.6
iu/ml
1.1
2.7
0.32
69
270
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
137
423
3.30
35.90
1.5
1.8
u/l
1007.9
2780.5
1.01
40
178
(3023419) Bacteria identified in Sputum by Culture
169
597
2.89
35.16
2.4
2.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
62
105
5.96
35.05
1.9
1.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
62
105
5.96
35.05
1.7
1.4
%
1.8
2.4
0.26
53
89
(3024932) HLA-DR beta [Type]
61
102
6.04
34.93
1.5
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
122
357
3.47
34.80
2.3
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
39
39
10.07
34.47
1.2
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
729
4580
1.68
34.05
9.4
7.3
%
95.7
95.1
1.87
702
4393
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
97
248
3.96
33.69
1.3
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
217
896
2.48
33.18
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
217
896
2.48
33.18
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
83
193
4.35
32.70
1.4
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3845
34006
1.45
32.36
40.5
16.2
%
14.4
13.7
121.43
3801
33113
(3047189) Immunofixation for 24 hour Urine
75
165
4.60
31.68
1.6
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
87
215
4.10
31.66
3.5
5.4
u/ml
36.8
770.1
—
6
43
(1616796) Gas panel - Central venous blood
221
947
2.39
31.16
3.9
3.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
202
837
2.47
30.66
1.5
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
353
1838
1.98
30.44
5.6
3.8
mmol/l
25.6
24.9
4.77
338
1684
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
23
11
20.99
30.29
1.3
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
63
126
5.05
29.80
4.9
1.1
u/ml
33.3
90.4
0.71
15
37
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
32
30
10.72
29.54
1.2
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
181
725
2.55
29.52
1.7
1.4
u/l
10.8
8.7
1.30
152
580
(3002173) Hemoglobin [Mass/volume] in Arterial blood
653
4132
1.66
29.41
10.1
7.7
g/l
113.1
122.6
23.89
624
3960
(40768797) Stomach Pathology biopsy report
865
5865
1.57
29.27
1.3
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
49
79
6.25
29.11
1.5
1.2
titre
42.1
58.7
—
9
9
(3010375) cycloSPORINE [Mass/volume] in Blood
68
149
4.61
28.89
32.3
25.6
ug/l
122.2
114.8
0.36
58
119
(40768800) Prostate Pathology biopsy report
108
332
3.30
28.56
1.2
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
577
3584
1.68
27.83
4.9
3.1
kpa
4.6
4.5
0.63
556
3453
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
171
693
2.52
27.24
1.2
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
26
20
13.06
27.12
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
212
952
2.28
26.85
4.3
4.2
mmol/l
2.9
2.5
1.47
169
636
(40761536) Microorganisms panel - Urine sediment
543
3353
1.69
26.73
4.7
4.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3013
25950
1.36
26.65
4.0
3.0
u/l
60.2
49.2
6.33
2810
23614
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
245
1174
2.14
26.44
1.7
1.5
g/l
1.1
1.2
1.06
237
1106
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
240
1148
2.14
26.02
1.7
1.5
g/l
0.2
0.2
0.71
222
1085
(3020393) Adenovirus Ag [Presence] in Stool
30
31
9.73
25.87
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
392
2241
1.81
25.29
12.5
9.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
215
996
2.21
25.27
3.3
3.0
kpa
8.1
7.9
0.53
202
916
(3035350) Ketones [Presence] in Urine by Test strip
2478
20828
1.35
25.01
4.3
3.7
estimate
0.0
0.0
0.50
592
3565
(3015235) Bicarbonate [Moles/volume] in Capillary blood
240
1166
2.11
25.00
3.2
3.1
mmol/l
24.6
24.8
0.25
216
1028
(3042010) Triglyceride [Moles/volume] in Pleural fluid
36
50
7.24
24.56
1.2
1.2
mmol/l
4.0
2.8
0.25
24
27
(3013862) HLA-DP [Type]
30
7
43.05
24.54
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
29
31
9.40
24.40
1.6
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
29
31
9.40
24.40
1.6
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
29
31
9.40
24.40
1.6
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
185
820
2.30
24.18
3.0
2.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
281
1466
1.97
24.06
2.7
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
73
195
3.78
23.93
1.1
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
73
196
3.76
23.76
1.4
1.2
%
61.5
51.2
0.40
14
21
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
377
2171
1.79
23.72
9.3
9.2
mmol/l
24.2
24.4
0.53
354
1986
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
93
293
3.21
23.69
1.1
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
29
7
41.60
23.59
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
29
7
41.60
23.59
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
29
7
41.60
23.59
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
29
7
41.60
23.59
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
498
3104
1.67
23.56
7.1
4.7
—
—
—
0
0
(3010421) pH of Blood
228
1117
2.09
23.24
4.3
4.1
ph
7.4
7.4
2.98
210
927
(3037522) Nuclear Ab [Titer] in Serum
775
5380
1.51
23.11
1.4
1.3
titre
665.8
506.2
1.14
163
1156
(3021601) Nitrite [Presence] in Urine by Test strip
2460
20829
1.33
22.86
5.7
5.0
estimate
0.0
0.0
0.80
604
3623
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4308
39752
1.41
22.20
31.5
12.5
ml/min/173m2
76.8
76.3
0.76
3914
31977
(3009261) Glucose [Presence] in Urine by Test strip
2479
21081
1.33
22.05
4.4
3.8
estimate
0.0
0.0
0.05
588
3485
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
21
0
+∞
21.88
1.0
0.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
144
598
2.45
21.83
1.2
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
27
7
38.79
21.69
1.9
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1404
10988
1.38
21.64
1.7
1.5
nmol/l
19.8
20.2
0.58
1228
9260
(3027273) Bicarbonate [Moles/volume] in Venous blood
394
2363
1.72
21.49
3.7
3.2
mmol/l
25.1
25.2
0.41
385
2277
(40767503) Oxygen content in Capillary blood by calculation
193
916
2.15
21.38
3.1
2.5
%
15.0
16.4
5.15
109
484
(3013512) EKG study
1674
13499
1.35
21.21
4.8
4.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
27
32
8.47
21.00
1.7
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
27
32
8.47
21.00
3.3
6.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
50
111
4.54
20.97
1.9
1.1
ug/l
4.2
3.0
0.19
36
90
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
519
3365
1.60
20.89
3.5
3.9
ng/l
84.3
96.0
1.90
436
2829
(3026250) Tacrolimus [Mass/volume] in Blood
56
139
4.06
20.37
32.0
33.7
ug/l
7.7
7.5
0.10
44
128
(21491868) Cryoglobulin [Mass/volume] in Serum
56
139
4.06
20.37
1.6
1.2
g/l
1.5
0.1
—
9
9
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
17
10
17.05
20.28
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
234
1216
1.97
20.28
3.6
3.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
624
4251
1.53
20.17
1.3
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
52
123
4.26
20.15
1.3
1.2
%
22.1
37.7
0.80
18
14
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
428
2670
1.65
20.11
9.9
9.0
%
0.7
0.7
0.07
421
2652
(3023323) Follitropin [Units/volume] in Serum or Plasma
165
755
2.22
20.04
1.7
1.3
iu/l
27.0
29.1
0.33
137
644
(40768441) Liver Pathology biopsy report
59
155
3.84
19.86
1.3
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
237
1251
1.94
19.63
1.2
1.4
—
17.9
—
0
29
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
31
47
6.63
19.55
1.4
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
188
916
2.09
19.48
1.3
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
428
2692
1.64
19.46
9.7
8.9
%
1.3
1.4
0.90
420
2675
(3030981) Hyaline casts [#/volume] in Urine by Automated count
375
2291
1.68
19.08
3.1
2.5
e6/l
0.4
0.3
0.55
369
2241
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
76
243
3.16
18.97
1.2
1.0
mg/l
485.1
283.6
2.24
63
214
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
68
204
3.36
18.81
1.3
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
42
89
4.75
18.66
1.3
1.3
ug/l
4.9
89.0
1.13
18
37
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
109
429
2.57
18.56
3.3
3.9
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
32
53
6.07
18.55
1.8
1.5
%
4.5
6.0
0.29
17
24
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
276
1559
1.81
18.51
1.6
1.6
titre
390.6
255.9
—
8
76
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
16
10
16.04
18.50
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
112
449
2.53
18.36
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
31
51
6.11
18.09
1.5
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
77
256
3.04
18.01
1.2
1.1
mg/l
72.4
39.3
3.24
60
211
(3011325) HIV 1+2 Ab [Presence] in Serum
16
11
14.59
17.61
1.1
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
34
63
5.42
17.57
2.1
1.3
ng/l
74.2
141.6
0.75
28
47
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
66
204
3.26
17.44
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
154
727
2.15
17.36
1.3
1.2
u/l
78.6
28.1
2.98
134
617
(3046861) Legionella sp Ag [Presence] in Urine
19
18
10.59
17.32
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
94
359
2.65
17.04
1.5
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
57
166
3.46
16.55
1.2
1.1
ng/l
1811.4
486.7
0.93
30
43
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.8
3.7
—
6
7
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.8
1.9
—
7
9
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.5
3.9
—
10
9
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.7
0.6
—
12
9
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.5
4.0
—
10
9
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.2
1.5
—
7
7
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
1.3
2.1
—
12
7
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
17
15
11.37
16.20
1.5
1.5
mg/l
0.8
1.7
—
10
7
(3011544) Albumin [Mass/volume] in Pleural fluid
22
28
7.89
16.14
1.1
1.1
g/l
14.7
14.1
0.15
22
23
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
39
88
4.46
16.09
1.3
1.4
%
16.9
28.1
1.65
34
69
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2534
22179
1.27
16.01
2.9
2.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
22
9
24.53
15.98
1.0
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
192
1017
1.92
15.79
2.5
2.2
g/l
121.6
130.8
4.82
139
750
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
58
177
3.30
15.68
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
65
213
3.08
15.63
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
244
1398
1.78
15.63
2.7
2.6
g/l
0.6
0.3
0.63
123
500
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
97
393
2.50
15.61
1.2
1.1
u/l
58.8
59.1
0.02
74
256
(3044889) 12 lead EKG panel
3388
30752
1.27
15.61
4.9
4.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
17
16
10.66
15.54
1.5
1.5
mg/l
1.4
2.7
—
8
8
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
62
199
3.14
15.44
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
62
199
3.14
15.44
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
704
5166
1.42
15.35
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
333
2090
1.63
15.25
2.6
2.9
pmol/l
4.2
4.4
3.24
297
1796
(3008152) Bicarbonate [Moles/volume] in Arterial blood
443
2978
1.53
15.10
9.8
6.9
mmol/l
24.9
24.5
1.08
410
2756
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
25
40
6.27
15.00
2.0
1.4
ng/l
115.7
125.5
0.14
15
18
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
342
2170
1.62
14.99
4.2
2.6
%
0.7
0.7
0.98
329
2072
(3004119) Hemoglobin [Mass/volume] in Venous blood
435
2919
1.53
14.95
4.5
3.2
g/l
119.5
130.3
17.90
427
2835
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
96
396
2.45
14.89
1.1
1.1
—
25.9
—
0
8
(44786800) Granulocytes/100 leukocytes in Body fluid
23
34
6.79
14.85
1.4
1.2
%
28.9
23.9
0.20
16
22
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
498
3447
1.49
14.76
3.2
2.4
ml/min/173m2
60.5
63.2
0.75
198
1323
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
31
62
5.02
14.76
1.5
1.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
346
2213
1.60
14.67
4.5
2.6
%
1.3
1.2
0.19
341
2196
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
14
11
12.76
14.25
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
207
1163
1.81
14.18
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3971
42201
0.78
14.07
4.4
4.7
mmol/l
1.4
1.4
21.18
3568
38466
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
60
201
3.01
13.93
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
207
1170
1.80
13.91
1.4
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
866
6678
1.35
13.87
25.7
28.9
inr
1.3
1.4
1.72
144
919
(40757373) Influenza virus identified in Isolate
38
95
4.02
13.77
1.6
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
19
8
23.81
13.77
1.7
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1390
11466
1.29
13.70
4.8
4.2
estimate
0.0
0.0
0.24
570
3521
(40765089) Chromosome analysis panel - Blood by G-banded
25
44
5.70
13.65
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
207
1177
1.79
13.64
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4119
43531
0.77
13.58
4.9
5.4
mmol/l
2.6
2.6
0.21
3699
39763
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
65
232
2.82
13.49
1.2
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
17
5
34.10
13.49
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
57
189
3.04
13.48
1.3
1.1
u/l
1.3
1.1
0.88
32
88
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
64
227
2.84
13.44
3.0
4.4
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
28
56
5.02
13.34
12.5
2.4
umol/l
40.6
46.1
0.53
23
49
(3041918) Cholesterol [Moles/volume] in Pleural fluid
33
76
4.36
13.31
1.1
1.2
mmol/l
1.5
1.4
0.26
23
38
(3047181) Lactate [Moles/volume] in Blood
234
1389
1.72
13.28
10.1
5.9
mmol/l
1.3
1.3
0.16
200
1215
(3019550) Sodium [Moles/volume] in Serum or Plasma
4686
44685
1.37
13.28
36.1
16.5
mmol/l
139.4
139.8
17.88
4630
43422
(4027681)
57
191
3.01
13.25
1.4
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
405
2758
1.51
12.98
2.3
2.2
nmol/l
12.7
14.6
5.23
371
2409
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3832
40784
0.79
12.81
5.9
6.4
mmol/mol
40.4
40.7
0.96
3472
37403
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4020
42545
0.78
12.81
4.6
4.8
mmol/l
4.5
4.5
2.02
3650
39052
(3051651) Icteric interference index of Serum or Plasma
57
196
2.93
12.68
4.5
4.2
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
25
48
5.23
12.47
1.1
1.3
u/l
32.6
749.1
0.48
19
30
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
300
1935
1.58
12.30
8.3
4.8
%
1.7
1.6
0.07
275
1809
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
367
2481
1.51
12.18
1.3
1.3
au/ml
76.8
53.7
—
10
110
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
36
95
3.81
12.15
1.1
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
4686
44797
1.35
12.12
36.7
16.6
mmol/l
4.0
4.0
0.54
4621
43455
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
397
2731
1.49
12.11
2.3
2.4
au/ml
32.3
25.3
—
6
109
(3019309) Folate [Moles/volume] in Red Blood Cells
1160
9492
1.28
11.94
1.8
1.8
nmol/l
1183.2
1152.7
0.50
908
7080
(3043410) Blood group antigens tested for on Red Blood Cells
38
106
3.60
11.85
3.7
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
80
339
2.38
11.78
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
593
4413
1.39
11.78
3.1
3.0
ng/l
264.7
219.5
1.44
553
4045
(3023183) Ammonium ion [Moles/volume] in Plasma
157
860
1.85
11.74
2.9
2.6
umol/l
33.9
34.8
0.15
137
729
(3026389) Candida sp identified in Specimen by Organism specific culture
110
534
2.08
11.66
1.3
1.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
17
9
18.94
11.57
1.5
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
35
94
3.74
11.54
1.7
1.4
—
—
—
0
0
(4281824)
59
218
2.73
11.53
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
345
2333
1.51
11.44
1.5
1.3
u/ml
773.7
236.4
0.98
297
2152
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
32
82
3.92
11.26
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1279
10659
1.26
11.23
4.1
3.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
44
140
3.16
11.21
1.1
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
21
38
5.54
11.16
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
290
1900
1.56
11.12
5.8
4.9
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
16
8
20.05
11.11
1.8
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
258
1649
1.59
11.02
1.5
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
17
25
6.82
11.01
1.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
15
19
7.91
11.00
1.9
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
140
762
1.86
10.71
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
63
251
2.53
10.63
1.3
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4703
45151
1.32
10.47
23.2
9.4
u/l
26.6
26.0
0.97
4643
43087
(3039162) Centromere protein B Ab [Units/volume] in Serum
98
476
2.08
10.42
1.3
1.2
u/ml
43.6
39.0
—
9
31
(3028679) Herpes simplex virus Ab [Presence] in Serum
45
153
2.96
10.27
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
161
929
1.76
10.18
1.2
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
25
58
4.33
10.03
1.2
1.1
%
65.6
42.2
1.52
14
27
(3007930) Methemoglobin/Hemoglobin.total in Blood
285
1907
1.52
9.96
8.9
4.8
%
0.9
0.9
0.67
262
1784
(3036603) Volume of Urine
62
254
2.46
9.89
1.5
1.4
ml
1832.3
1943.7
0.19
15
58
(3003327) Ova and parasites identified in Stool by Light microscopy
194
1190
1.65
9.82
1.8
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
34
101
3.38
9.70
2.1
1.8
—
—
—
0
0
(40758358) Immune stain study
9
0
+∞
9.38
1.0
0.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
109
3.23
9.29
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
19
38
5.01
9.08
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
155
918
1.71
8.98
1.1
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
14
21
6.68
8.89
2.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
14
21
6.68
8.89
1.6
1.0
ug/l
1.8
1.6
—
8
9
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
51
4.33
8.85
1.4
2.5
—
—
—
0
0
(3039000) Anion gap in Blood
162
978
1.68
8.76
13.2
6.7
mmol/l
10.8
11.4
1.77
141
870
(3018572) Chloride [Moles/volume] in Blood
162
978
1.68
8.76
13.2
6.7
mmol/l
105.3
104.9
0.45
141
870
(3009542) Hematocrit [Volume Fraction] of Blood
3929
37150
1.21
8.71
32.8
15.0
%
37.5
39.6
31.43
2549
24236
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1667
14607
1.20
8.67
2.2
2.2
u/l
174.6
236.8
1.48
1580
13592
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3884
40822
0.83
8.57
4.3
4.3
mmol/l
1.3
1.3
4.48
3486
36876
(3000570) Elastase.pancreatic [Mass/mass] in Stool
189
1196
1.60
8.49
1.5
1.4
ug/g
264.6
288.0
0.96
118
710
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
36
121
2.99
8.44
2.5
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1007
11952
0.81
8.43
1.8
1.7
mmol/l
1.5
1.4
3.26
862
9860
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4688
45216
1.28
8.39
39.9
15.8
umol/l
83.5
81.2
3.54
4688
45199
(3011397) Hemoglobin [Presence] in Urine by Test strip
1208
10285
1.22
8.38
4.2
3.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
33
106
3.13
8.35
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
33
106
3.13
8.35
1.1
1.1
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
8
0
+∞
8.33
1.0
0.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
166
1033
1.63
8.01
1.2
1.2
titre
111.1
109.7
0.02
18
87
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
38
136
2.81
7.99
1.1
1.1
miu/ml
1085.4
1732.0
3.24
38
136
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
32
104
3.09
7.96
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
56
243
2.32
7.95
1.7
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
28
84
3.35
7.92
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1809
16077
1.19
7.87
4.7
4.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
55
242
2.29
7.58
1.8
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
10
12
8.35
7.58
1.4
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
47
193
2.45
7.55
1.4
5.3
mg/l
71.6
69.2
0.05
40
129
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
56
249
2.26
7.53
1.8
1.4
nmol/l
0.2
0.3
0.22
43
199
(40761539) Cells [Type] in Urine sediment by Light microscopy
28
87
3.23
7.51
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
108
2.97
7.48
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
80
411
1.96
7.41
4.0
3.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
243
1677
1.47
7.38
4.7
4.1
mmol/l
1.6
1.4
0.99
234
1642
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
32
109
2.95
7.37
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
126
750
1.70
7.25
3.0
3.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
138
843
1.65
7.20
1.3
1.2
u/ml
1.5
6.1
1.12
14
66
(3003740) Influenza virus B Ag [Presence] in Specimen
77
395
1.96
7.18
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2151
19507
1.17
7.14
2.1
2.1
pmol/l
91.7
94.3
1.58
1216
9995
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
70
3.44
7.10
1.6
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
50
219
2.30
6.99
2.1
1.9
u/field
1.8
1.8
0.04
38
147
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
40
158
2.54
6.99
2.9
2.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
239
1664
1.46
6.96
2.0
2.3
ug/l
389.1
626.3
0.72
222
1568
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
126
759
1.68
6.95
1.3
1.2
u/ml
30.1
43.0
0.58
16
85
(3033086) Enterovirus NOS Ab [Titer] in Serum
11
8
13.77
6.88
1.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
8
13.77
6.88
2.2
3.9
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
8
13.77
6.88
2.2
3.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
27
87
3.11
6.85
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
76
396
1.93
6.79
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
29
99
2.94
6.68
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
92
514
1.80
6.63
9.5
20.8
mmol/l
7.5
7.4
0.12
78
417
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
12
21
5.72
6.58
1.2
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
52
238
2.20
6.58
1.4
1.3
u/l
32.3
30.9
0.11
46
169
(3034770) Mitochondria Ab [Titer] in Serum
161
1047
1.55
6.53
1.2
1.2
—
1163.7
—
0
35
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
165
1079
1.55
6.52
1.4
1.2
u/ml
51.5
45.3
0.12
19
61
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
47
208
2.27
6.45
1.5
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
77
413
1.88
6.34
1.3
1.4
mosm/kgh2o
274.6
278.7
1.05
63
316
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
9
5
18.03
6.26
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
117
712
1.66
6.25
1.6
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
154
1005
1.55
6.17
1.4
1.2
u/ml
2.2
2.5
0.25
26
99
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
155
1014
1.54
6.14
1.4
1.2
u/ml
2.2
5.1
1.78
30
161
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3384
31969
1.16
6.09
4.2
3.8
pmol/l
15.0
15.0
0.90
3082
28598
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
33
129
2.57
5.94
2.4
2.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
41
178
2.31
5.91
1.5
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
19
55
3.46
5.72
1.1
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
44
200
2.21
5.71
1.1
1.1
u/l
47.8
24.7
0.90
35
144
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
44
200
2.21
5.71
1.1
1.1
u/l
113.9
87.3
1.05
38
150
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
46
3.70
5.64
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
18
51
3.54
5.59
2.2
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
203
1439
1.43
5.44
5.2
4.5
mmol/l
3.8
3.9
0.92
180
1357
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
5
16.03
5.41
1.9
6.6
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
8
5
16.03
5.41
1.1
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
190
2666
0.70
5.40
1.8
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
122
780
1.58
5.40
1.4
1.3
mmol/l
58.8
63.6
0.70
100
629
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
43
3.73
5.36
1.0
1.1
—
—
—
0
0
(4212803)
14
34
4.13
5.35
1.2
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
9
8
11.27
5.28
1.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
9
8
11.27
5.28
1.1
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
22
5.01
5.26
3.8
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
12
26
4.62
5.25
1.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
215
1554
1.40
5.18
1.4
1.2
u/ml
6.8
0.9
1.11
14
154
(3020682) Albumin/Creatinine [Ratio] in Urine
1422
15792
0.86
5.13
3.9
4.0
mg/mmol
10.4
8.7
0.70
902
10021
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
40
3.76
5.08
1.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
18
55
3.28
5.02
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
90
547
1.66
4.92
1.2
1.2
u/ml
2.7
4.4
0.58
25
179
(3002621) Streptococcal DNAse B [Units/volume] in Serum
14
37
3.79
4.81
1.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
18
57
3.17
4.75
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
344
4336
0.78
4.75
1.5
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
47
3.41
4.74
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1193
13345
0.86
4.68
3.0
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
180
1288
1.41
4.64
1.8
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4492
43650
1.17
4.56
27.6
13.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
46
235
1.97
4.48
1.6
1.5
u/l
9.0
5.4
0.53
27
99
(3044927) Protein electrophoresis panel - Urine
87
539
1.62
4.45
1.1
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
24
94
2.56
4.37
1.1
1.9
g/l
16.7
14.3
0.67
19
72
(3019977) pH of Arterial blood
49
259
1.90
4.33
4.1
2.2
ph
7.4
7.4
0.39
18
102
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
10
22
4.55
4.30
1.5
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
138
955
1.46
4.29
6.0
3.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
251
1922
1.32
4.25
2.0
1.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
16
51
3.14
4.20
1.9
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
27
4.08
4.16
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
121
1737
0.69
3.99
1.4
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
23
93
2.48
3.95
1.5
2.4
e6/l
12744.6
36932.5
0.50
17
49
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
51
283
1.81
3.92
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
51
283
1.81
3.92
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1362
14943
0.88
3.89
3.3
3.2
mg/l
1153.2
293.9
3.96
868
9549
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
51
284
1.80
3.88
1.2
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
45
241
1.87
3.86
1.7
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
181
2412
0.74
3.82
1.4
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
51
286
1.79
3.80
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
51
286
1.79
3.80
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
51
286
1.79
3.80
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
56
2.86
3.62
4.3
4.6
—
—
—
0
0
(4268621)
61
366
1.67
3.60
2.0
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
83
539
1.55
3.56
1.2
1.2
u/ml
2.8
4.7
1.68
32
240
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
105
2.29
3.51
1.1
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
11
32
3.44
3.33
1.1
1.1
iu/ml
16.2
9.9
—
5
12
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
7
8.58
3.26
7.8
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
85
1250
0.67
3.26
1.4
1.6
mg/l
4.6
3.9
0.24
66
883
(3009508) Creatinine [Moles/volume] in Urine
1416
15358
0.89
3.23
3.1
3.2
mmol/l
7.2
7.5
1.88
1153
12801
(3033705) Calcium.ionized [Moles/volume] in Venous blood
88
593
1.49
3.22
3.0
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
461
3919
1.19
3.18
4.1
3.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
524
4514
1.18
3.10
2.2
2.2
ug/g
182.5
156.4
0.70
437
3515
(3004451) EKG impression Narrative
41
231
1.78
3.07
1.3
1.3
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
6
8
7.51
3.05
1.2
1.1
mg/l
2.5
1.2
—
6
8
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
8
7.51
3.05
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
16
5.01
3.05
1.1
1.1
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
5
5
10.01
2.98
1.4
1.0
mg/l
18.7
42.4
—
5
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1119
10228
1.12
2.80
1.7
1.7
pmol/l
12432923.8
33558279.4
0.91
925
8314
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
490
1.50
2.77
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
100
1381
0.72
2.75
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
22
104
2.12
2.74
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
19
85
2.24
2.70
1.8
2.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
24
3.75
2.67
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
24
3.75
2.67
1.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
21
100
2.10
2.58
1.5
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
19
87
2.19
2.56
2.4
2.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
48
300
1.61
2.52
2.5
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
56
366
1.54
2.44
2.3
2.2
u/field
1.5
1.8
0.22
26
133
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
29
159
1.83
2.43
2.5
2.0
ug/l
36.5
53.5
2.13
29
153
(3000330) Specific gravity of Urine by Test strip
285
2383
1.21
2.42
3.9
3.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
8
22
3.64
2.36
1.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
157
1236
1.28
2.31
4.5
4.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
35
2.86
2.30
1.1
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
37
223
1.66
2.27
1.8
1.8
umol/l
6.1
7.8
0.44
23
151
(3037556) Urate [Mass/volume] in Serum or Plasma
6
169
0.35
2.27
3.3
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
20
100
2.00
2.20
1.1
1.1
%
78.6
87.7
0.48
12
48
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
50
329
1.52
2.16
1.1
1.2
—
117.5
—
0
12
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
79
571
1.39
2.11
2.1
2.3
mg/l
27.0
25.7
0.08
23
143
(3035320) C reactive protein [Mass/volume] in Body fluid
44
283
1.56
2.10
2.1
2.5
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
10
37
2.71
2.10
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
27
153
1.77
2.07
1.3
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
72
516
1.40
2.03
1.1
1.1
g/l
1.6
1.5
1.80
72
450
(3047007) Chlamydophila sp Ab [Presence] in Serum
67
475
1.42
2.01
1.2
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
26
3.08
2.01
1.4
3.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
512
0.62
1.96
1.0
1.1
u/ml
8.7
1.6
—
10
226
(3039443) Prostate specific Ag panel - Serum or Plasma
62
868
0.71
1.95
1.7
1.6
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
16
3.75
1.93
1.2
1.1
nmol/l
222.6
248.2
—
6
16
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
25
142
1.76
1.92
1.2
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
20
106
1.89
1.90
1.2
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
57
399
1.43
1.86
1.2
1.7
u/ml
42.0
23.6
—
6
99
(3051387) C reactive protein [Mass/volume] in Capillary blood
125
988
1.27
1.85
3.8
3.6
mg/l
29.1
28.3
0.10
86
639
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
59
2.21
1.84
1.2
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
17
3.53
1.83
1.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
6
17
3.53
1.83
2.0
1.6
%
2.0
1.5
—
6
17
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
101
1.88
1.80
1.2
1.1
%
76.8
86.3
0.54
11
46
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
50
715
0.70
1.80
1.4
1.4
—
—
—
0
0
(4015189)
26
153
1.70
1.79
1.3
2.6
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
8
29
2.76
1.79
1.1
1.5
ml/s/173m2
1.3
1.0
—
8
17
(3007461) Platelets [#/volume] in Blood
4741
46781
1.11
1.77
49.9
19.9
e9/l
220.9
243.1
81.39
4656
45276
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
61
437
1.40
1.77
1.9
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
49
337
1.46
1.76
1.2
1.3
titre
38.0
79.7
—
5
29
(3024731) MCV [Entitic volume]
4742
46794
1.11
1.76
49.7
19.9
fl
91.9
91.4
11.98
4701
45899
(3035941) MCH [Entitic mass]
4742
46796
1.11
1.75
49.6
19.8
pg
30.5
30.4
0.73
4701
45902
(3027456) Digoxin [Moles/volume] in Serum or Plasma
131
1050
1.25
1.74
3.1
3.1
nmol/l
0.9
0.8
0.46
94
814
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
6
18
3.34
1.74
1.7
1.1
u/field
1.3
1.0
—
6
8
(3026361) Erythrocytes [#/volume] in Blood
4742
46800
1.11
1.74
49.9
19.9
e12/l
4.2
4.5
198.69
4644
45098
(3000963) Hemoglobin [Mass/volume] in Blood
4742
46807
1.11
1.71
50.1
20.1
g/l
126.6
136.4
270.21
4699
45923
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
40
266
1.51
1.70
1.0
1.1
nmol/l
0.1
8.6
—
6
61
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
519
4678
1.12
1.70
2.3
2.4
ug/l
7.1
7.6
0.16
445
4048
(3010813) Leukocytes [#/volume] in Blood
4742
46809
1.11
1.70
49.9
20.0
e9/l
6.7
6.8
0.40
4646
45106
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
55
2.18
1.67
2.4
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
31
2.58
1.65
1.1
1.9
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
21
119
1.77
1.65
2.6
2.3
ug/l
1.0
1.1
0.14
21
108
(3029396) Erythrocyte agglutination [Presence] in Blood
7
25
2.80
1.65
1.0
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
135
1.71
1.62
6.3
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
135
1.71
1.62
6.3
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
153
1849
0.82
1.62
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
38
254
1.50
1.60
1.8
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
32
2.50
1.59
1.0
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
42
287
1.47
1.59
2.4
2.1
min
498.9
496.5
0.05
23
216
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
26
2.69
1.58
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
34
226
1.51
1.48
1.8
2.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
202
1.54
1.48
1.2
1.2
ratio
1.2
1.1
0.41
11
61
(4024509)
61
453
1.35
1.47
1.4
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
13
66
1.97
1.43
1.5
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
29
188
1.55
1.42
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
104
1283
0.81
1.38
1.7
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
433
0.67
1.37
1.0
1.1
u/ml
1.8
1.3
—
8
194
(3001729) Color of Synovial fluid
9
42
2.14
1.33
1.8
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
24
2.50
1.30
1.5
10.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
39
276
1.42
1.28
1.3
1.5
umol/l
15.3
13.7
0.74
39
255
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
443
0.70
1.20
1.0
1.1
u/ml
8.2
4.5
0.36
11
228
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
35
247
1.42
1.18
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
57
436
1.31
1.18
1.1
1.1
u/ml
2.4
2.9
0.27
17
163
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
27
393
0.69
1.16
1.0
1.0
ng/l
38.9
45.0
0.82
18
245
(4306422)
67
526
1.28
1.15
1.3
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
42
309
1.36
1.13
1.2
1.2
mmol/l
32.4
34.4
0.34
42
258
(3051101) Glucose [Moles/volume] in Cord blood
5
114
0.44
1.12
6.4
6.7
—
—
—
0
0
(3000492) Spirometry study
407
3718
1.10
1.11
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
43
319
1.35
1.10
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
71
566
1.26
1.09
1.1
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3973
39128
1.06
1.08
4.9
4.6
mu/l
2.7
2.1
0.45
3636
35257
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
39
286
1.37
1.08
1.3
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
33
2.12
1.05
1.6
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
277
0.65
1.04
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
653
6112
1.08
1.04
12.5
7.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
56
712
0.78
1.03
1.6
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
22
2.27
1.03
6.6
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
240
0.62
1.03
1.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
47
1.92
1.02
1.1
1.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
9
47
1.92
1.02
5.3
5.1
ug/min
45.7
46.1
—
9
33
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
244
2182
1.12
1.01
1.2
1.2
iu/ml
104.3
132.6
0.51
69
810
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
189
1.43
0.98
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
49
1.84
0.98
1.1
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
28
390
0.72
0.98
1.0
1.0
ng/l
399.4
336.2
0.30
19
249
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
28
390
0.72
0.98
1.0
1.0
ng/l
735.7
720.3
0.05
18
243
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
102
857
1.19
0.98
1.8
1.8
iu/l
8.2
4.7
0.87
30
271
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
163
1862
0.87
0.98
1.5
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
892
0.82
0.97
1.6
1.6
nmol/l
1.0
0.8
1.77
61
731
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
31
0.00
0.96
0.0
2.0
—
1.4
—
0
25
(3045716) Anion gap in Serum or Plasma
33
242
1.37
0.94
1.8
2.2
mmol/l
9.3
9.4
0.12
22
182
(3014271) Vancomycin [Susceptibility]
35
260
1.35
0.93
2.4
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
321
2935
1.10
0.90
3.1
3.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
118
1015
1.17
0.89
2.4
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
66
538
1.23
0.88
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
63
772
0.81
0.88
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
252
2281
1.11
0.87
1.3
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
56
1.79
0.87
1.3
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
62
503
1.24
0.87
1.2
1.3
nmol/l
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
41
317
1.30
0.85
1.4
1.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
19
129
1.47
0.83
1.6
1.4
ug/l
10.4
9.2
0.29
19
129
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
24
171
1.41
0.82
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
46
1.74
0.82
1.1
1.5
—
—
—
0
0
(4034850)
136
1548
0.88
0.81
13.6
9.9
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
33
249
1.33
0.81
1.3
1.4
u/l
8.7
6.7
0.37
25
213
(44806420)
10
165
0.61
0.81
3.1
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1869
18167
1.04
0.81
4.6
3.9
ug/l
3.0
2.3
0.98
1645
16302
(42529582) MDA5 Ab [Presence] in Serum by Line blot
19
130
1.46
0.80
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
19
130
1.46
0.80
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
19
130
1.46
0.80
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
19
130
1.46
0.80
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
47
1.70
0.80
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
65
536
1.22
0.80
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
271
2477
1.10
0.80
2.5
2.5
—
—
—
0
0
(4010399)
309
3356
0.92
0.80
1.4
1.4
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.1
—
37.2
—
0
8
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
31
233
1.33
0.79
2.3
2.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
26
0.00
0.78
0.0
1.4
—
340.1
—
0
26
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
187
2080
0.90
0.78
1.6
1.8
—
—
—
0
0
(4146454)
47
582
0.81
0.75
3.1
2.7
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
9
53
1.70
0.75
1.0
1.4
—
112.4
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
5
24
2.08
0.74
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
19
133
1.43
0.73
1.2
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
25
2.00
0.72
1.0
1.4
—
—
—
0
0
(4198724)
6
109
0.55
0.72
1.0
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
17
117
1.45
0.71
4.5
4.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
43
344
1.25
0.71
10.4
2.1
%
10.4
11.2
0.53
43
344
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
123
1393
0.88
0.71
1.5
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
395
4217
0.93
0.69
1.6
1.7
%
1.5
1.5
0.79
331
3619
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
17
118
1.44
0.69
1.2
1.7
%
256.5
184.6
1.62
17
111
(3028707) Methadone [Presence] in Urine by Screen method
26
342
0.76
0.69
1.2
2.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
162
1456
1.12
0.69
1.6
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
62
519
1.20
0.68
1.3
1.3
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
5
27
1.85
0.68
1.2
1.2
—
27.4
—
0
9
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
59
1.53
0.68
2.8
2.5
u/field
0.4
0.5
—
9
59
(3016879) Cocaine [Presence] in Urine
56
671
0.83
0.67
1.2
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
215
0.70
0.67
1.0
1.0
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
44
1.59
0.65
1.1
1.5
pmol/l
81.4
47.8
—
7
34
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
62
730
0.85
0.62
1.3
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
79
1.52
0.62
2.3
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
19
138
1.38
0.62
1.1
1.1
u/ml
2.9
1.3
—
8
47
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
23
173
1.33
0.61
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
110
1238
0.89
0.60
1.9
1.5
e6/l
13964.2
12981.3
0.08
89
900
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
9
139
0.65
0.60
3.8
2.5
nmol/l
139.6
142.6
—
9
121
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
15
105
1.43
0.60
2.1
2.4
mmol/l
6.6
8.0
—
10
67
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
1.1
—
0
16
(3027944) Amphetamines [Presence] in Urine
60
703
0.85
0.58
1.2
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
114
0.61
0.58
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
61
712
0.86
0.57
1.1
2.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
100
886
1.13
0.57
1.9
1.9
pmol/l
205.0
202.1
0.08
95
836
(3004616) Nuclear Ab [Presence] in Serum
62
531
1.17
0.56
1.4
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
177
1.30
0.54
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
70
609
1.15
0.53
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1052
10204
1.04
0.52
2.8
2.8
ug/l
0.7
0.7
0.29
720
7032
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
326
0.80
0.51
1.0
1.1
u/ml
11.1
2.9
—
7
138
(4094501)
115
1273
0.90
0.50
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
79
894
0.88
0.50
1.7
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
202
0.74
0.50
1.4
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
41
1.46
0.50
1.3
1.1
u/l
5.3
10.1
—
6
41
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
258
0.77
0.50
1.0
1.1
u/ml
0.6
0.4
—
5
78
(3020491) Glucose [Moles/volume] in Blood
26
324
0.80
0.49
1.2
2.2
mmol/l
8.1
6.8
1.05
19
215
(3005011) Chlamydia sp Ab [Titer] in Serum
7
45
1.56
0.49
1.4
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
45
1.56
0.49
1.7
2.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
645
0.87
0.47
4.6
4.7
umol/l
303.9
356.9
2.01
47
548
(3027008) Opiates [Presence] in Urine
63
716
0.88
0.45
1.1
2.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
563
5854
0.96
0.44
4.3
4.9
%
30.9
32.8
3.73
393
3872
(3000285) Sodium [Moles/volume] in Blood
10
69
1.45
0.44
1.3
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
104
1.35
0.43
1.2
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
36
304
1.19
0.41
1.6
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
58
1.38
0.41
7.3
12.5
mmol/l
8.4
5.3
—
8
58
(3004775) Volume in Urine collected for unspecified duration
48
416
1.16
0.41
2.6
2.3
ml
802.5
628.1
1.26
27
280
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
64
720
0.89
0.40
1.1
2.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
34
1.47
0.40
1.2
2.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
35
296
1.18
0.40
1.0
1.2
mmol/l
13.3
11.8
0.52
13
86
(3006270) Folate [Moles/volume] in Blood
48
418
1.15
0.39
1.1
1.2
nmol/l
343.8
341.9
0.02
38
340
(3041806) Other cells [#/volume] in Blood by Manual count
5
35
1.43
0.39
1.6
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
26
214
1.22
0.39
1.0
1.1
iu/ml
17.8
12.9
—
5
46
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
119
1292
0.92
0.39
2.5
2.3
ug/min
161.8
122.7
0.27
71
756
(1001926) Buprenorphine [Presence] in Urine by Screen method
49
559
0.88
0.38
1.2
2.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
302
0.83
0.38
1.0
1.1
u/ml
1.6
4.4
—
8
127
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
637
6580
0.96
0.38
1.2
1.2
u/ml
11.0
15.0
0.73
216
2429
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4202
42280
0.97
0.37
5.0
5.0
mmol/l
6.0
6.1
3.59
3808
38063
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
20
161
1.24
0.37
2.6
2.7
umol/l
25.3
29.1
0.85
14
121
(3006653) Thiamine [Moles/volume] in Blood
25
207
1.21
0.36
1.2
1.2
nmol/l
122.1
140.0
2.21
25
207
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
40
347
1.15
0.35
1.3
1.2
u/ml
95.0
73.6
—
7
16
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
42
1.43
0.35
1.7
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
179
0.78
0.35
2.1
1.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
20
162
1.24
0.35
1.5
2.4
umol/l
97.4
150.1
0.75
13
90
(3008898) HLA-B27 [Presence]
114
1053
1.08
0.35
1.0
1.1
—
—
—
0
0
(44813793)
20
244
0.82
0.34
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
44
1.36
0.34
1.8
2.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
44
1.36
0.34
1.0
1.2
umol/24h
2.2
1.7
—
6
44
(3019150) Specific gravity of Urine by Refractometry
987
9648
1.03
0.33
4.8
4.2
kg/l
1.0
1.0
0.52
162
1461
(3010144) Erythrocytes [#/volume] in Synovial fluid
55
491
1.12
0.33
1.6
1.3
e6/l
12095.4
210942.6
5.17
39
336
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
861
8402
1.03
0.33
1.2
1.3
u/ml
1.7
2.0
0.26
189
2155
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
455
4392
1.04
0.33
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
86
0.70
0.33
1.0
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
109
1011
1.08
0.32
1.1
1.1
u/ml
4.9
7.0
0.45
11
89
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
128
1.25
0.31
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
58
642
0.90
0.30
1.7
1.5
%
58.8
61.9
0.24
36
419
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
100
928
1.08
0.29
1.3
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
54
487
1.11
0.29
3.3
3.0
mg/l
21.6
32.0
0.62
39
364
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
52
471
1.11
0.26
1.6
1.5
%
34.8
28.4
0.58
34
311
(3036071) Salmonella sp Ab [Titer] in Serum
13
104
1.25
0.26
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
86
1.28
0.26
1.1
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
73
1.23
0.25
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
23
264
0.87
0.23
1.8
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
15
125
1.20
0.22
1.1
1.1
u/ml
0.4
1.1
—
5
34
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
50
545
0.92
0.22
1.2
1.3
pmol/l
254.0
274.0
0.27
39
409
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1.3
—
0
5
(3012989) Citrate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
2.4
—
0
12
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
360.5
—
0
13
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
14
0.00
0.20
0.0
5.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
2.0
1.9
umol/l
20.4
19.5
—
6
51
(3036670) Protein [Mass/volume] in Synovial fluid
15
175
0.86
0.18
1.7
1.2
g/l
37.0
39.2
—
10
92
(3025577) Chromium [Mass/volume] in Blood
33
362
0.91
0.17
2.1
2.0
ug/l
2.2
2.2
0.09
28
301
(3011288) Drugs identified in Urine by Screen method
50
466
1.07
0.16
1.2
3.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
121
1.16
0.15
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
86
901
0.95
0.14
1.3
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
141
1.14
0.13
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
98
0.82
0.13
1.0
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
23
253
0.91
0.13
1.3
1.3
nmol/l
1.0
1.3
0.78
17
190
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
284
0.92
0.13
1.2
1.3
u/ml
0.4
1.0
0.83
12
144
(3022689) Creatine [Moles/volume] in Urine
17
151
1.13
0.13
2.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
231
0.91
0.12
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
231
0.91
0.12
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
109
1129
0.96
0.12
1.6
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
116
0.86
0.12
7.9
7.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
230
0.91
0.11
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
230
0.91
0.11
1.5
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
201
1.09
0.11
2.8
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1454
14643
0.99
0.11
4.1
3.8
%
21.5
24.2
9.02
714
7175
(3013139) Helicobacter pylori Ag [Presence] in Stool
279
2841
0.98
0.10
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3482
34919
0.99
0.10
43.7
17.9
g/l
331.2
332.5
14.13
3453
34613
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
44
1.14
0.10
6.6
11.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
196
0.92
0.09
1.6
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
60
577
1.04
0.08
1.2
1.3
mu/l
53.0
68.6
0.46
51
508
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
1.3
2.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
45
471
0.96
0.08
1.2
1.2
mmol/l
7.6
7.8
0.15
35
335
(3023511) Choriogonadotropin [Units/volume] in Urine
23
214
1.08
0.08
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
133
0.90
0.07
7.1
7.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
31
327
0.95
0.07
1.5
1.4
pmol/l
65.2
164.8
0.48
14
92
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
337
0.95
0.07
1.4
1.3
promille
1.2
1.3
0.19
21
255
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
245
0.94
0.07
1.6
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
25
265
0.94
0.07
2.3
2.2
ug/min
15.1
207.3
—
7
66
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
237
1.06
0.05
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
192
0.94
0.05
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
191
0.94
0.04
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
695
6983
0.99
0.04
1.2
1.3
iu/ml
43.0
38.2
0.29
220
2134
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
102
1.08
0.03
1.5
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
309
3076
1.00
0.02
1.2
1.2
—
—
—
0
0
(4211845)
23
223
1.03
0.01
2.7
3.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
64
634
1.01
0.00
1.1
1.1
iu/ml
1.5
301.8
—
8
135
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
105
1.05
0.00
1.2
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
23
235
0.98
0.00
1.5
1.5
%
1.7
4.4
—
7
51
(3051593) INR in Capillary blood by Coagulation assay
25
255
0.98
0.00
10.2
10.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
96
1.04
0.00
7.9
7.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
143
0.98
0.00
1.3
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
42
423
0.99
0.00
1.3
1.3
nmol/l
1.3
1.5
0.37
34
383
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
1.6
1.5
umol/l
45.4
43.7
—
5
51
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
88
0.91
0.00
1.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
9
94
0.96
0.00
1.3
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.8
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
31.4
—
0
7
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.8
—
0.3
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
3.8
—
20.7
—
0
6
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
55
0.91
0.00
1.2
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
89
0.90
0.00
1.4
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1206.0
—
0
5
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1167.1
—
0
7
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
37.1
—
0
8
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
121.4
—
0
5
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
134.8
—
0
5
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_NONHODGKIN_EXALLC – Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
GWS hits: 10
This endpoint is excluded (different definition than used in FinnGen).